Literature DB >> 9049403

The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum.

I S Lukashevich1, M Djavani, K Shapiro, A Sanchez, E Ravkov, S T Nichol, M S Salvato.   

Abstract

The large (L) RNA segment of Lassa fever virus (LAS) encodes a putative RNA-dependent RNA polymerase (RdRp or L protein). Similar to other arenaviruses, the LAS L protein is encoded on the genome-complementary strand and is predicted to be 2218 amino acids in length (253 kDa). It has an unusually large non-coding region adjacent to its translation start site. The LAS L protein contains six motifs of conserved amino acids that have been found among arenavirus L proteins and core RdRp of other segmented negative-stranded (SNS) viruses (Arena-, Bunya- and Orthomyxoviridae). Phylogenetic analyses of the RdRp of 20 SNS viruses reveals that arenavirus L proteins represent a distinct cluster divided into LAS-lymphocytic choriomeningitis and Tacaribe-Pichinde virus lineages. Monospecific serum against a synthetic peptide corresponding to the most conserved central domain precipitates a 250 kDa product from LAS and lymphocytic choriomeningitis virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049403      PMCID: PMC2405892          DOI: 10.1099/0022-1317-78-3-547

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

Review 1.  Bunyavirus RNA synthesis: genome transcription and replication.

Authors:  D Kolakofsky; D Hacker
Journal:  Curr Top Microbiol Immunol       Date:  1991       Impact factor: 4.291

2.  Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains.

Authors:  O Poch; B M Blumberg; L Bougueleret; N Tordo
Journal:  J Gen Virol       Date:  1990-05       Impact factor: 3.891

3.  The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein.

Authors:  M S Salvato; E M Shimomaye
Journal:  Virology       Date:  1989-11       Impact factor: 3.616

4.  Tacaribe virus L gene encodes a protein of 2210 amino acid residues.

Authors:  S Iapalucci; R Lopez; O Rey; N Lopez; M T Franze-Fernandez; G N Cohen; M Lucero; A Ochoa; M M Zakin
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

5.  Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA.

Authors:  D D Auperin; D R Sasso; J B McCormick
Journal:  Virology       Date:  1986-10-15       Impact factor: 3.616

6.  Virus-specific proteins and RNAs from cells infected with hemorrhagic fever with renal syndrome (HFRS) viruses derived from endemic areas of the U.S.S.R.

Authors:  I S Lukashevich; E A Tkachenko; N N Lemeshko; G V Rezapkin; T A Stelmakh; A J Pashkov; E P Stchesljenok
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

7.  Nucleotide sequence conservation at the 3' termini of the virion RNA species of New World and Old World arenaviruses.

Authors:  D D Auperin; R W Compans; D H Bishop
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

8.  The primary structure of the lymphocytic choriomeningitis virus L gene encodes a putative RNA polymerase.

Authors:  M Salvato; E Shimomaye; M B Oldstone
Journal:  Virology       Date:  1989-04       Impact factor: 3.616

9.  Ribonucleic acids of Machupo and Lassa viruses.

Authors:  I S Lukashevich; T A Stelmakh; V P Golubev; E P Stchesljenok; N N Lemeshko
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

10.  Tomato spotted wilt virus L RNA encodes a putative RNA polymerase.

Authors:  P de Haan; R Kormelink; R de Oliveira Resende; F van Poelwijk; D Peters; R Goldbach
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

View more
  36 in total

1.  A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases.

Authors:  Jeremy A Bruenn
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

2.  Domain structure of Lassa virus L protein.

Authors:  Linda Brunotte; Michaela Lelke; Meike Hass; Katja Kleinsteuber; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

3.  Replicon system for Lassa virus.

Authors:  Meike Hass; Uta Gölnitz; Stefanie Müller; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence.

Authors:  Ana Grande-Pérez; Gema Gómez-Mariano; Pedro R Lowenstein; Esteban Domingo
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses.

Authors:  Dmitry A Moshkoff; Maria S Salvato; Igor S Lukashevich
Journal:  Virus Genes       Date:  2006-12-02       Impact factor: 2.332

6.  Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.

Authors:  Igor S Lukashevich; Ricardo Carrion; Maria S Salvato; Keith Mansfield; Kathleen Brasky; Juan Zapata; Cristiana Cairo; Marco Goicochea; Gia E Hoosien; Anysha Ticer; Joseph Bryant; Harry Davis; Rasha Hammamieh; Maria Mayda; Marti Jett; Jean Patterson
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

7.  An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome.

Authors:  Michaela Lelke; Linda Brunotte; Carola Busch; Stephan Günther
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

Review 8.  VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

Authors:  Pierre Leblanc; Leonard Moise; Cybelle Luza; Kanawat Chantaralawan; Lynchy Lezeau; Jianping Yuan; Mary Field; Daniel Richer; Christine Boyle; William D Martin; Jordan B Fishman; Eric A Berg; David Baker; Brandon Zeigler; Dale E Mais; William Taylor; Russell Coleman; H Shaw Warren; Jeffrey A Gelfand; Anne S De Groot; Timothy Brauns; Mark C Poznansky
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 9.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

10.  Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome.

Authors:  Meike Hass; Michaela Lelke; Carola Busch; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.